Search

We are excited to announce a new publication by Dr. Rebecca Campbell-Montalvo, Director of the AQUASS Lab, in collaboration with Dr. Ashutosh Shukla (PI) and his research team, now available in Patient Education and Counseling: Understanding how patient education affects the process of treatment...

Co-Director and Founder of IVHI, Dr. Yael Bensoussan, discusses the potential to detect diseases through the sound of one's voice, using advanced machine learning techniques.

This new study spearheaded by Satinder Kaur and Peri Sohnen with able support from the rest of the team elucidates that SLURP1 serves as an insult-agnostic immunomodulator that upregulates antioxidants and suppresses ROS accumulation to promote redox homeostasis in corneal epithelial cells and...

The Swamynathan laboratory welcomed Dr. Asmita Pawar and Dr. Pooja Yadav as post-doctoral fellows.

Transgenex Nanobiotech Inc., a biotechnology spinout from the University of South Florida founded by Drs. Shyam and Subhra Mohapatra, received a $1.49 million Phase II Small Business Innovation Research (SBIR) contract from the National Cancer Institute on March 27, 2017. The contract, announced by...

On Jan. 20, 2016, the American Institute for Medical and Biological Engineering (AIMBE) announced that Dr. Shyam Mohapatra would be inducted into its prestigious College of Fellows. According to AIMBE, the honor recognizes his outstanding contributions in biomedical nanotechnology and his leadership...

In 2006, Dr. Shyam Mohapatra initiated major research grants to develop siRNA-based prophylactics for respiratory syncytial virus (RSV). He secured a VA Merit Review award (April 2005–March 2009) to study RNA-interference strategies targeting the virus’s NS1 and NS2 genes, laying the groundwork for...

New year, new publication! In this paper, we show that the apicobasal polarity determinant PARD3 regulates human corneal epithelial cell proliferation, extracellular matrix-binding, migration, F-actin polymerization, and barrier function. Loss of PARD3 activity pushes the corneal epithelial cells...